{
    "title": "AbbVie sees strong 2022 earnings as Botox, Skyrizi power profit beat",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10468297/AbbVie-sees-strong-2022-earnings-Botox-Skyrizi-power-profit-beat.html",
    "date": "2022-02-02",
    "keywords": [
        "share",
        "company",
        "profit",
        "drug",
        "skyrizi",
        "year",
        "botox",
        "psoriasis",
        "performance",
        "humira",
        "rinvoq",
        "quarter",
        "forecast",
        "fullyear",
        "street",
        "wednesday",
        "blockbuster",
        "antiwrinkle",
        "injection",
        "growth",
        "loss",
        "exclusivity",
        "market",
        "abbvie",
        "purchase",
        "covid19",
        "arthritis",
        "eczema",
        "copycat",
        "europe",
        "revenue",
        "increase",
        "consideration",
        "liability",
        "drugmaker",
        "bell",
        "reporting",
        "bengaluru",
        "editing",
        "daniel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}